Editorial Article
The Same Honey, Five Times the Invoice: Why a Food Authenticity Test Is Priced by the Label and Not by the Laboratory
There are two published prices for a food authenticity determination in Europe, and the gap between them is not explained by the science.
The first is a species determination by real-time PCR. It is quoted at EUR 150 to EUR 550 per sample, accredited to ISO 17025, with a detection limit of 0.1 per cent and a turnaround of about two weeks. It will tell you whether the fish in a fillet is the fish on the label, and a few hundred laboratories worldwide can run it.
The second is a manuka honey authentication. New Zealand’s Ministry for Primary Industries defines the claim in five attributes — four chemical markers and one DNA marker from manuka pollen — and a United Kingdom laboratory prices the DNA marker alone at GBP 246 per sample in a five-sample pack. That is one of five required determinations. The sample is the same size. The laboratory is the same laboratory. The instrument is a qPCR platform in both cases.
The difference is the number of things the label asserts.
The claim is the unit of sale
This is the mechanism that governs pricing in the whole market, and it is unusual enough to be worth stating slowly. A food authenticity test is not priced by what it costs to run. It is priced by how many separate propositions the buyer has to be able to defend.
A generic species check defends one proposition: this is cod. A monofloral manuka claim defends five at once, and a failure on any of them is a misdescription. A Protected Designation of Origin claim defends origin, method and, where a blend is involved, proportion. A “single origin” claim defends a provenance statement that nobody has defined numerically.
Which means the invoice tracks the label, not the assay. And it means the commercially important question in this market is not “how many samples will be tested” but “how many adjectives will be printed on the pack”.
| Claim | Attributes the claim requires | Published price signal |
|---|---|---|
| Species identity (fish, meat) | One: the species | EUR 150–550 per sample, accredited, 0.1% detection limit |
| Monofloral manuka honey | Five: four chemical markers plus one pollen DNA marker | GBP 246 per sample for the DNA marker alone |
| Honey country of origin, blended | One per declared origin, plus the proportion of each | No published catalogue method for the proportion |
| Extra virgin olive oil | Free acidity, peroxide value, sterols, triglycerides, sensory panel | Panel and chromatography priced separately |
The last two rows are where the next phase of this market sits, and they behave differently from the first two. A species claim is verifiable and cheap because the reference exists — a DNA barcode and, since November 2024, certified reference materials for pollack and saithe produced by the Joint Research Centre so that laboratories can be confident their sequencing results are accurate. An origin proportion is not verifiable at all, in the sense that no published method measures the share of a blend.
Why there is no compliance product here
The reason this market has so little pricing power, and grows so fast anyway, is that nothing in it is a pass or a fail.
In pathogen testing, a result is compared with a published reference method and a legal criterion, and the output is a status. In mycotoxin testing, a concentration is compared with a statutory limit and the output is a status. In allergen testing the analogy breaks — no statutory reference method exists for allergen detection, and that market gives price back rather than capturing it.
Authenticity has neither a limit nor a reference method. A food is not required to contain a minimum quantity of anything in order to be what it is; it is required only not to be misdescribed. So no laboratory can sell compliance, because there is no compliance certificate to sell. It sells suspicion, and then it sells the work of turning a suspicion into something a lawyer can use.
The European Commission’s own data shows what suspicion looks like at scale. In the coordinated control plan on imported honey, 320 consignments from 20 exporting countries were sampled by 15 Member States plus Switzerland and Norway, and the Joint Research Centre found 147 — 46 per cent — suspicious of containing added sugars. In the herbs and spices plan, 1,885 samples went through nearly 10,000 analyses and 17 per cent were suspicious, with oregano at 48 per cent, mostly extended with olive leaves.
And then the sentence that caps the market: the Commission states that current analytical methods are not yet developed enough at international level and a simple test is not sufficient to detect adulteration, and that proper follow-up of suspicions is necessary. In the honey action, 44 operators were investigated and seven were sanctioned. Roughly one suspicion in six became a case.
The deflation underneath the invoice
Here is the countervailing force, and it is why realised price per sample in this market grows at 0.48 per cent a year while invoices rise.
Proton NMR profiling has become the most consequential technology in the category precisely because one run answers many questions. Bruker’s FoodScreener, at 400 MHz, runs push-button automated analysis against matrix-specific databases. The honey method detects exogenous sugars, verifies country of origin, verifies botanical variety, assesses composition and freshness, flags atypical samples, and performs a regulatory compliance check against EU and Codex criteria for HMF, sucrose and glucose and fructose. The database behind it holds roughly 28,500 reference samples across more than 50 countries and 100 monofloral types.
One platform replaces a series of targeted assays. When one run replaces three, revenue per sample falls even as information per sample rises. That is deflation, and it is measurable: minus USD 45.5 million of the growth in this market between 2025 and 2033 is pure assay price decline in Pheonix Research’s model.
But the same run produces determinations for origin, variety, purity, freshness and compositional compliance at once. A customer who used to buy one answer now receives five, and the label being defended asserts five things. That is claim density, and it is worth USD 157.7 million of growth over the same period.
| Component of growth, 2025–2033 | USD million | Share of the USD 1,330.0m total |
|---|---|---|
| More samples | 1,217.9 | 91.6% |
| More claims per sample (claim density) | 157.7 | 11.9% |
| Falling assay prices | −45.5 | −3.4% |
| Total growth | 1,330.0 | 100% |
So the market’s price story is two stories moving in opposite directions, and the net of them is a number that looks like stagnation. The competitive implication is straightforward: a laboratory that competes on assay price is competing on the part of its business that is shrinking. The part that grows is the number of propositions it can defend at once — which is a function of its reference data and its interpretive capability, not its instrument list.
What a buyer should actually procure
The practical consequence for anyone buying this work is that the unit of procurement is wrong almost everywhere it appears. Contracts are written per sample, per batch, per consignment. The exposure they are trying to control is per claim.
A retailer with 400 private-label lines, each carrying an average of three verifiable provenance or composition claims, has 1,200 propositions to defend and is buying perhaps 200 samples a year against them. The mismatch is not a procurement failure; it is the market’s own structure. It is also why the advisory layer of this market grows faster than the analytical layer, since the work of deciding which 1,200 claims are worth defending is not a laboratory service.
What would change the price
One event would move this market from a volume story to a price story, and it has a date. Under Directive (EU) 2024/1438, the Commission is empowered to adopt delegated acts on composition criteria, on ensuring that pollen is not removed from honey, and on methods and criteria to determine where honey was harvested — due by 14 June 2029.
A pollen-content criterion and an invertase index are numerical limits. A numerical limit is the only thing that has ever supported price capture in food testing. Across the five reports in this cluster, the categories where a threshold is published capture between a third and a half of their growth in price, and the category with no threshold gives price back. If the 2029 acts arrive as numbers, authenticity testing stops being an investigative service and starts being a compliance product — and the invoice stops depending on the adjective and starts depending on the limit.
Until then, the honest position is the one the Commission states in its own enforcement findings: the test produces a suspicion, the follow-up produces a case, and the price of the first is set by how much of the second the market can actually finish.
This article draws on the Pheonix Research report Global Food Authenticity & Adulteration Testing Market, 2026–2033, and on the European Commission’s coordinated control plan findings for honey (2021–2022) and culinary herbs and spices (2019–2021), the JRC certified reference materials for fish species identification, and published laboratory rate cards. Related reading: allergen testing, where the absence of a reference method has the opposite effect on price.
Read the companion piece: On 14 June 2026 Honey Labels Start Asserting Percentages. No Published Method Can Prove One. — on what the Breakfast Directive actually requires, and why the percentage on the jar is a records claim rather than a measurement.
Frequently Asked Questions
Why does a food authenticity test cost more than a species test?
Because the unit of sale is the claim, not the assay. A species determination defends one proposition and is quoted at EUR 150–550 per sample. A monofloral manuka claim is defined in five attributes and one laboratory prices the pollen DNA marker alone at GBP 246 per sample. Same sample, same instrument, one to five times the invoice depending on what the label asserts.
Is the food authenticity testing market growing?
Yes, at 7.67 per cent compound from USD 1,650.0 million in 2025 to USD 2,980.0 million in 2033 — the fastest growth in the food safety testing cluster. But 91.6 per cent of that growth is more samples rather than a higher price, and falling assay prices remove 3.4 per cent.
Why is the price per test falling while invoices rise?
Because platforms now answer several questions in one run. Proton NMR profiling against a reference database of roughly 28,500 honey samples replaces a series of targeted assays, which lowers revenue per sample even as information per sample rises. Realised revenue per sample grows only from USD 196.43 to USD 204.11 over eight years, or 0.48 per cent a year.
What does the buyer actually get for the money?
A suspicion, and then the work of turning it into a defensible position. Authenticity has no statutory limit and no statutory reference method, so no test result carries automatic legal force. In the European Commission's honey action, 44 operators were investigated on the back of the testing and seven were sanctioned — roughly one suspicion in six became a case.
